Towards improved detection of subclinical atrial fibrillation – Who could benefit from targeted screening?
Saved in:
| Main Authors: | Anke C. Fender, Dobromir Dobrev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | International Journal of Cardiology: Heart & Vasculature |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906724002161 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inflammatory gut-heart interactions: Is there a link between inflammatory bowel disease and atrial fibrillation?
by: Dobromir Dobrev, et al.
Published: (2024-12-01) -
Screening for atrial fibrillation after stroke: is targeted patient selection the key?
by: Thaís Leite Secchi, et al.
Published: (2024-10-01) -
Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
by: Rudolf A de Boer, et al.
Published: (2021-12-01) -
Characterisation of patients who develop atrial fibrillation-induced cardiomyopathy
by: Guy Lloyd, et al.
Published: (2024-11-01) -
The Effect of Direct Anticoagulant Therapy on Haematological Parameters in Atrial Fibrillation: Clinical Significance of Subclinical Haemoglobin Decrease
by: Metin Çoksevim, et al.
Published: (2024-11-01)